id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-346287-xg176mi7	Wan, Marilyn T.	In response to: “Reply to Research Letter.”	2020-07-29		.txt	text/plain	450	35	58	Letter to the Editor 1 2 To the Editor: We appreciate the interest of Rivera-Oyola, Koschitzky, and Lebwohl 1 in our 3 meta-estimate evaluating the risk of respiratory tract infections (RTIs) and symptoms in patients 4 2 The authors make a 5 cogent case for the importance of not cherry-picking data when evaluating drug safety by 6 selecting a few examples in which perhaps patients treated with IL-17 inhibitors have a lower 7 risk of RTIs compared to placebo. publication, 2 the results demonstrated a statistically significant 31-56% increased risk of RTI in 10 IL-17 targeting biologic treated patients compared to placebo. The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A metaestimate of pivotal trials relevant to decision-making during the COVID-19 pandemic The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic	./cache/cord-346287-xg176mi7.txt	./txt/cord-346287-xg176mi7.txt